TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 49 filers reported holding TAYSHA GENE THERAPIES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,740,000 | +378.1% | 1,500,000 | 0.0% | 0.66% | +518.7% |
| Q2 2023 | $991,500 | -17.1% | 1,500,000 | 0.0% | 0.11% | -10.8% |
| Q1 2023 | $1,196,400 | -64.7% | 1,500,000 | 0.0% | 0.12% | -64.5% |
| Q4 2022 | $3,390,000 | +251.3% | 1,500,000 | +200.0% | 0.34% | +263.4% |
| Q3 2022 | $965,000 | -48.1% | 500,000 | 0.0% | 0.09% | -30.6% |
| Q2 2022 | $1,860,000 | -42.9% | 500,000 | 0.0% | 0.13% | -30.6% |
| Q1 2022 | $3,260,000 | -44.0% | 500,000 | 0.0% | 0.19% | +11.6% |
| Q4 2021 | $5,825,000 | -37.4% | 500,000 | 0.0% | 0.17% | -26.4% |
| Q3 2021 | $9,310,000 | -12.2% | 500,000 | 0.0% | 0.24% | +5.4% |
| Q2 2021 | $10,600,000 | +4.4% | 500,000 | 0.0% | 0.22% | 0.0% |
| Q1 2021 | $10,150,000 | -23.5% | 500,000 | 0.0% | 0.22% | -19.2% |
| Q4 2020 | $13,270,000 | +18.5% | 500,000 | 0.0% | 0.28% | 0.0% |
| Q3 2020 | $11,200,000 | – | 500,000 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,827,926 | $12,096,246 | 8.11% |
| TCG Crossover Management, LLC | 11,111,111 | $35,111,111 | 5.17% |
| VR Adviser, LLC | 14,444,444 | $45,644,443 | 4.80% |
| Kynam Capital Management, LP | 3,281,313 | $10,368,949 | 1.70% |
| Ghost Tree Capital, LLC | 1,325,000 | $4,187,000 | 1.38% |
| Octagon Capital Advisors LP | 2,777,778 | $8,777,778 | 1.35% |
| RA Capital Management | 18,472,503 | $58,373,109 | 1.15% |
| RTW INVESTMENTS, LP | 16,893,185 | $53,382,465 | 1.13% |
| Diametric Capital, LP | 760,014 | $2,401,644 | 1.00% |
| Quantum Private Wealth, LLC | 575,380 | $1,818,201 | 0.87% |